FULLER & THALER ASSET MANAGEMENT, INC. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$6,891,000
-13.3%
438,342
-0.4%
0.08%
-21.9%
Q4 2017$7,952,000
+184.0%
440,300
+203.4%
0.10%
+182.4%
Q3 2017$2,800,000
+328.1%
145,100
+161.9%
0.03%
+277.8%
Q2 2017$654,000
+7.7%
55,4000.0%0.01%
+12.5%
Q1 2017$607,000
+87.3%
55,400
+24.2%
0.01%
+60.0%
Q4 2016$324,000
+489.1%
44,600
+424.7%
0.01%
+400.0%
Q3 2016$55,0008,5000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders